Brian Walter Metcalf

USPTO Granted Patents = 87 (Patent Applications = 13)

CIPO Patents = 13 (Patent Applications = 7)

EPO Patents = 25 (Patent Applications = 15)

Average Co-Inventor Count = 4.3

ph-index = 20

Forward Citations = 1,216(Granted Patents)

Inventors with similar research interests:

Location History:

Moraga Town, CA (US) (2004)
South San Francisco, CA (US) (2016 - 2022)
Moraga, CA (US) (2002 - 2024)

Company Filing History:

Global Blood Therapeutics, Inc.

patents

17 out of 147

Incyte Holdings Corporation

patents

4. 8 out of 110

Kosan Biosciences Incorporated

University of California

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

87 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12084449 - Imidazotriazines and imidazopyrimidines as kinase inhibitors (2024-09-10),

2. 11530191 - Compounds and uses thereof for the modulation of hemoglobin (2022-12-20),

3. 11401280 - Pyrimidinones as PI3K inhibitors (2022-08-02),

4. 11286243 - Ferroportin inhibitors and methods of use (2022-03-29),

5. 11261191 - Imidazotriaines and imidazopyrimidines as kinase inhibitors (2022-03-01),

6. 11236109 - Compounds and uses thereof for the modulation of hemoglobin (2022-02-01),

7. 11014884 - Modulators of hemoglobin (2021-05-25),

8. 10829502 - Pyrimidinones as PI3K inhibitors (2020-11-10),

9. 10829470 - Compounds and uses thereof for the modulation of hemoglobin (2020-11-10),

10. 10822326 - Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation (2020-11-03),

11. 10806733 - Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation (2020-10-20),

12. 10738052 - Imidazotriaines and imidazopyrimidines as kinase inhibitors (2020-08-11),

13. 10435393 - Compounds and uses thereof for the modulation of hemoglobin (2019-10-08),

14. 10428087 - Pyrimidinones as PI3K inhibitors (2019-10-01),

15. 10377741 - Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation (2019-08-13),

Sure, here is an article about inventor Brian Walter Metcalf:

Title: Unveiling the Inventive Mind of Brian Walter Metcalf

Introduction:

Brian Walter Metcalf, a prolific inventor based in Moraga, CA (US), has established himself as a leading figure in the field of biopharmaceutical innovations. With an impressive portfolio of 86 patents, Metcalf's contributions have significantly impacted the realms of hemoglobin modulation and PI3K inhibition.

Latest Patents:

Metcalf's recent patents showcase his innovative prowess:

1. "Compounds and uses thereof for the modulation of hemoglobin" - Metcalf's groundbreaking work introduces compounds and pharmaceutical compositions that serve as modulators of hemoglobin. These inventions offer promising avenues for treating disorders related to hemoglobin and enhancing tissue and cellular oxygenation.

2. "Pyrimidinones as PI3K inhibitors" - His invention of pyrimidinones as inhibitors of phosphoinositide 3-kinases (PI3Ks) presents novel therapeutic strategies for addressing conditions such as inflammatory disorders, immune-based disorders, cancer, and other related diseases.

Career Highlights:

Metcalf's impactful innovations have been nurtured through his collaborations with renowned companies in the biopharmaceutical sector. He has contributed his expertise to prominent organizations such as Incyte Corporation and Global Blood Therapeutics, Inc., where his inventive spirit has flourished in creating groundbreaking solutions for complex medical challenges.

Collaborations:

Throughout his career, Metcalf has had the privilege of working alongside talented individuals such as Jincong Zhuo and Meizhong Xu. These collaborative efforts have not only enriched his inventive journey but have also led to the development of cutting-edge technologies that continue to shape the landscape of biopharmaceutical advancements.

Conclusion:

In conclusion, Brian Walter Metcalf's remarkable achievements in the field of biopharmaceutical innovations underscore his unwavering commitment to pushing the boundaries of scientific exploration. His inventive legacy serves as an inspiration for aspiring inventors and underscores the transformative power of innovation in driving progress within the healthcare industry.

If you have any more specific requests or inquiries, feel free to ask.

This text is generated by artificial intelligence and may not be accurate.